Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
25%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
25%
ALSO IN AGNG
AGNG
84
HOLDINGS
16%
ALSO IN CANC
SECTOR DRIFT (CANC minus AGNG)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in AGNG |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 4.8% | 3.6% | 3.6% | |
| MERCK & CO. INC. | 3.6% | 3.0% | 3.0% | |
| BRISTOL-MYERS SQUIBB CO | 3.3% | 3.0% | 3.0% | |
| ASTRAZENECA PLC | 3.5% | 2.8% | 2.8% | |
| ABBVIE INC | 2.8% | 3.2% | 2.8% | |
CANC Overweight Relative to AGNG
| REVOLUTION MEDICINES, INC. | 7.1% | |
| ROCHE HOLDINGS LTD-SPONS ADR | 4.2% | |
| COGENT BIOSCIENCES INC | 4.1% | |
| NOVARTIS AG | 4.1% | |
| IMMUNOME, INC. | 3.9% | |
| CELCUITY INC. | 3.6% | |
| LEGEND BIOTECH CORPORATION SPONSORED | 3.5% | |
| NUVALENT, INC. CLASS A | 3.4% | |
| BRIDGEBIO PHARMA, INC. | 2.8% | |
| GENMAB A/S SPONSORED ADR | 2.4% |
CANC Underweight Relative to AGNG
| NOVO NORDISK A/S-B | -3.8% | |
| EDWARDS LIFESCIENCES CORP | -3.4% | |
| ROCHE HOLDING AG-BR | -3.2% | |
| WELLTOWER, INC. | -3.1% | |
| VENTAS INC | -3.1% | |
| UCB SA | -2.9% | |
| STRYKER CORP | -2.8% | |
| SANDOZ GROUP AG | -2.6% | |
| MEDTRONIC PLC | -2.6% | |
| BOSTON SCIENTIFIC CORP | -2.4% |